• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Why Mycronic (OM:MYCR) Is Up 21.1% After Raising 2026 Revenue Guidance On Strong H1 Results

    Simply Wall St·07/16/2026 02:23:39
    Listen to the news
    • In July 2026, Mycronic AB (publ) reported past second-quarter 2026 results showing sales of SEK 2,416 million and net income of SEK 527 million, alongside higher earnings per share versus the prior year.
    • For the first half of 2026, Mycronic’s higher sales and net income were accompanied by an upgraded full-year revenue outlook to SEK 9.25 billion, indicating improved expectations for its business pipeline.
    • With Mycronic raising its 2026 revenue guidance, we’ll now assess how this brighter outlook interacts with its existing investment narrative.

    Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

    Mycronic Investment Narrative Recap

    To own Mycronic, you need to believe in sustained demand for its advanced production equipment and the company’s ability to turn a strong order book into profitable growth despite macro uncertainty and tariffs. The upgraded 2026 revenue outlook to SEK 9.25 billion reinforces the short term catalyst of solid execution on its backlog, while the biggest near term risk remains weaker High Flex demand and tariff related delivery delays, which this quarter’s results do not fully resolve.

    Among recent announcements, the June and April SLX mask writer orders in Asia and Europe stand out as most relevant, because they feed directly into the Pattern Generators backlog that underpins Mycronic’s raised guidance. These orders help offset earlier concerns about softer order intake in some divisions, but they also heighten the importance of converting the SEK denominated backlog efficiently in the face of currency swings and any renewed hesitation to invest.

    Yet while the guidance upgrade looks encouraging, investors should still be aware of how prolonged weakness in High Flex order intake could...

    Read the full narrative on Mycronic (it's free!)

    Mycronic's narrative projects SEK11.2 billion revenue and SEK2.0 billion earnings by 2029.

    Uncover how Mycronic's forecasts yield a SEK260.25 fair value, a 25% downside to its current price.

    Exploring Other Perspectives

    OM:MYCR 1-Year Stock Price Chart
    OM:MYCR 1-Year Stock Price Chart

    Some of the most optimistic analysts were already assuming revenue could reach about SEK 12.3 billion and earnings SEK 2.1 billion by 2029, so this guidance upgrade may either support that bullish view or highlight how fragile it is if Pattern Generators orders were to slow again.

    Explore 2 other fair value estimates on Mycronic - why the stock might be worth 25% less than the current price!

    Reach Your Own Conclusion

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Ready For A Different Approach?

    The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.